Jayson Donald Alexander Dallas

Jayson Donald Alexander Dallas, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Aimmune Therapeutics, Inc., Arena Pharmaceuticals Inc and Ultragenyx Pharmaceutical Inc. In total, 33 filings cover trades dated from 1 June 2016 to 11 March 2022.

The open-market side counts 5 purchases for €133k alongside 4 sales for €231k. Sales outweigh purchases by €98k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 20 share grants.

In size, the median ticket on the buying side is €1,207. On 1 out of 5 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 11 March 2022: a transaction, in Arena Pharmaceuticals Inc. The last purchase on record was published on 15 December 2020, which is 2,138 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.